SHUTTLE PHARMACEUTICALS HOLDINGS, INC.

NASDAQ:SHPH
Annual Meeting

of Shareholders

MEETING DATE

09/03/2026
DEF 14A FILED
08/13/2026
PUBLISHED
08/13/2026 8:30 pm
TIME TO PUBLISH
08/15/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:SHPH· CUSIP 825693401 · CLASS common stock · CIK 0001757499

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

5
FOR
0
AGAINST
0
WITHHOLD
5
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Approve, for purposes of Nasdaq Listing Rule 5635, the issuance of the Company’s shares of common stock in connection with the transactions contemplated by that certain Merger Agreement, dated April 30, 2026, pursuant to which the Company acquired United Dogecoin Inc., including shares issuable upon conversion of shares of Series B-1 Preferred Stock and upon the conversion of pre-funded warrants.
other
Routine
For
Board FOR · Duopoly unknown No divergence flagged

Stockholder approval is required to permit issuances and conversions in excess of the Exchange Cap.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Approve, for purposes of Nasdaq Listing Rule 5635, the issuance of the Company’s shares of Common Stock in connection with the transactions contemplated by that certain Securities Purchase Agreement, dated April 30, 2026, including shares issuable upon conversion of shares of Series B-2 Preferred Stock, upon exercise of common stock purchase warrants and upon the conversion of pre-funded warrants.
other
Routine
For
Board FOR · Duopoly unknown No divergence flagged

Stockholder approval is required to permit issuances and conversions in excess of the Exchange Cap.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Approve an amendment to the Company’s 2018 Equity Incentive Plan to increase the number of shares of Common Stock authorized for issuance thereunder to 8,800,000.
compensation
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The filing states current remaining shares are not sufficient for anticipated future granting needs following the Merger.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Approve an amendment to the Company’s Certificate of Incorporation to change the name of the Company to United Compute Inc.
other
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The filing states the new name more accurately reflects the Company’s business following the Merger.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
Approve any adjournment of the Special Meeting from time to time, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, one or more of the other proposals to be voted on at the Special Meeting.
other
Routine
For
Board FOR · Duopoly unknown No divergence flagged

The filing states adjournment could permit further solicitation if there are insufficient votes for other proposals.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

3a4e06636d37069d92a5608964afede6502c23ad6c9c61b042d2e87870a956f4

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates